G. A. Ghazaryan

G. A. Ghazaryan

Auto-generated profile, based on publicly available information

G. A. Ghazaryan

N.V. Sklifosovsky Research Institute for Emergency Medicine

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2024 in Medical alphabet
Verified
Journal Article
Closed access
PDF file
LTL. G. Tyurina
L. G. Tyurina
LKL. T. Khamidova
L. T. Khamidova
NRN. V. Ryubalko
N. V. Ryubalko
SKS. A. Koltashova
S. A. Koltashova
EKE. V. Kislukhina
E. V. Kislukhina
GGG. A. Gazaryan
G. A. Gazaryan
Aim. The study aimed at evaluating the role of the left ventricular (LV) longitudinal strain (LS) measurement and the left ventricle myocardial work parameters in predicting coronary artery disease (CAD), and determining the indications for early invasive diagnosis and treatment in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS).Materials and methods. The study included 51 patients aged from 41 to 93 years who were admitted at the Institute clinic with a diagnosis of NSTE-ACS. Upon admission, the risk of hospital mortality was assessed using GRACE risk score; standard echocardiography (EchoCG) and speckle tracking echocardiography (ST EchoCG) were performed to assess the LV longitudinal strain and the LV myocardial work parameters, and coronary angiography (CAG) was performed within 48 hours. The comparison group consisted of 20 volunteers without CAD.Results. According to the risk assessment with the GRACE score, the patients with low and moderate risk made 41 and 47 %, respectively. Local contractility disorders during standard EchoCG were detected in 15 patients (29 %). When analyzing regional parameters of longitudinal strain and myocardial work, the greatest prognostic value in identifying patients with hemodynamically significant changes in the coronary arteries (CAs) was demonstrated by the functional risk area (FRA) of 4 or more adjacent segments with a myocardial work index ≤1400 mmHg x% (sensitivity and specificity 84,2 and 78,1 %, AUC=0,83). In the dysfunctional segments of the risk zone in almost all patients, a paradoxical mechanism of deformation was detected in the form of post-systolic shortening with a post-systolic index (PSI) reaching a value of ≥20 % at least in one of the adjacent segments. The combination of a significant increase in PSI and the detection of FRA limited to 3 segments indicated the acuity of coronary insufficiency, hemodynamically significant stenosis (sensitivity and specificity 84 % and 79 %). When distributing patients, taking into account the data of standard EchoCG and ST EchoCG with the assessment of myocardial work, in the absence of significant disturbances in systolic function, the patients with intact main CAs or insignificant changes in the main CAs prevailed; among patients without visual impairment of contractility, the detected FRA indicated a hemodynamically significant damage of one of the main CAs; a combination of local contractility disorders and additional FRA was associated with multiple CA damage.Conclusion. The use of ST EchoCG with the assessment of myocardial work and identification of the functional risk area in NSTE-ACS patients makes it possible to predict CAD, detect patients at risk of an unfavorable outcome regardless of the GRACE risk level, determine indications for immediate invasive diagnostics, and choose the optimal method of revascularization.

15 April 2025 in Russian Sklifosovsky Journal "Emergency Medical Care"
Verified
Journal Article
Open access
PDF file
DMD. Markhulia
D. Markhulia
KPK. A. Popugaev
K. A. Popugaev
DSDmitry Sychev
Dmitry Sychev
MVM. V. Vatsik-Gorodetskaya
M. V. Vatsik-Gorodetskaya
GGG. A. Gazaryan
G. A. Gazaryan
STSvetlana Tuchkova
Svetlana Tuchkova
RELEVANCE. Acute coronary syndrome (ACS) is one of the most common cardiovascular diseases associated with increased mortality and disability of patients. Regarding the factor of genetic resistance to antiplatelet therapy, and we get an even more serious problem faced by cardiologists around the world. The study of antiplatelet therapy and resistance to it is a pressing issue in modern cardiology. This is important not only for determining the effectiveness of treatment for each patient, but also for personalizing therapy based on genetic characteristics. This allows improving the effectiveness of treatment and preventing recurrent cardiovascular complications. As a result, the study of antiplatelet therapy and resistance to it is an important aspect in the treatment of ACS. This helps prevent recurrent cardiovascular complications, improve the effectiveness of treatment and develop new methods of therapy.AIM OF THE STUDY. ST-segment elevation ACS (STEMI) based on a personalized approach to antiplatelet therapy and modification of the program to predict the course and outcome. To study the possibilities of various laboratory diagnostic methods for assessing the platelet component of hemostasis in patients with STEMI depending on (1) the combination of antiplatelet drugs used (aspirin + clopidogrel; aspirin + ticagrelor); (2) the presence of factors of genetic resistance to antiplatelet agents.MATERIAL AND METHODS. The study included patients with STEMI who underwent percutaneous coronary intervention in the infarct-related artery territory , a total of 46 patients (13 women, 33 men) aged 35 to 83 years, average age 61.7 years. Patients were divided into groups according to the received combination of dual antiplatelet therapy (DAPT) aspirin + clopidogrel (23 patients), aspirin + ticagrelor (23 patients), groups with and without genetic determination (GD ) were assessed. The platelet component of hemostasis was assessed in three different ways: standard coagulogram, aggregometry, rotation thromboelasthometry. The following pharmacogenetic markers were determined in all patients: CYP2C19*17, CYP2C19*2, CYP2C19*3, SLCO1B1 , CYP3A5*3 . LOF alleles were detected in 32 patients (67%). Among them, in the group taking aspirin in combination with clopidogrel, three subgroups of patients were distinguished: 7 patients in the slow metabolizer (SM) subgroup, 8 patients in the general rapid metabolizer subgroup , and 8 patients without LOF alleles were designated as normal metabolizers. In the group taking aspirin in combination with ticagrelor, 9 patients with intermediate metabolism were identified. Seven patients in the SM group. Seven patients without LOF alleles were classified as NM group. The course of the disease and its outcomes were assessed.RESULTS. Against the background of the use of antiplatelet agents, at research points 2 and 3, the values of the CT-EXTEM parameter statistically significantly increased compared to research point 1 and went beyond the reference values, reflecting drug-induced hypocoagulation of the platelet hemostasis link (66.1±2 and 96.3±14.3 s, respectively, p=0.02). It was especially important that in the group with GR, the CT-EXTEM parameter did not change either by research point 2 or by research point 3, reflecting platelet normal or hypercoagulation.CONCLUSION. Aggregometry parameters do not allow adequate assessment of the state of the platelet hemostasis link and its response to antiplatelet therapy in patients with acute coronary syndrome with ST segment elevation. Among the studied traditional and viscoelastic hemostatic parameters, the only parameter that should be used to assess the state of the platelet hemostasis link and its response to antiplatelet therapy is the CT-EXTEM test.

6 May 2024 in Medical alphabet
Verified
Journal Article
Closed access
PDF file
GNG. A. Nefedova
G. A. Nefedova
GGG. A. Gazaryan
G. A. Gazaryan
GTG. P. Titova
G. P. Titova
The aim of the study was to investigate the peculiarities of STEMI morphogenesis after mechanical restoration of epicardial blood flow without ECG signs of reperfusion. The autopsy data of 44 patients with STEMI who died at different times after PCI performed within the first 12 hours (27 cases), or 12–24 hours (17 cases), without ECG signs of reperfusion after the intervention, were analyzed. The comparison group consisted of 85 deceased without reperfusion therapy (RT). Histological examination of the myocardium was performed at following time: within 12 hours, at 13–24 hours, 2–4 days, 5–8 days, 9–15 and 16–22 days. The most common cause of death was acute left ventricular failure (ALVF) both in the group of blood flow restoration without ECG signs of reperfusion, and in the group without RT: 85 % and 79 %, respectively. In each of the two groups the number of deaths occurred in the first 12 hours exceeded one third, half of the patients died in the subsequent 12 hours, two thirds of the deaths occurred within further 2–3 days. The rates of risk factors: older age, anterior and recurrent myocardial infarction, three-vessel lesion of the coronary artery, and a large infarction area were similar in the two groups. From the first hours after PCI, the infarction zone was characterized by hemorrhagic imbibition, numerous injuries of the microcirculatory bed, by the signs of blood flow restoration in damaged vessels appeared from days 2–4, early manifestations of repair from days 5–7. In the MI group without PCI, the hemorrhagic demarcation started on days from 3–4, coagulation necrosis prevailed in the microvascular bed, signs of repair appeared at a later date. Multiple spasms and thromboses in the microvasculature may have been a response to a blood pressure drop that accompanies an acute decrease in the left ventricle contractile function caused by a large infarction area and/or unresolved complications arising during the interventions per se. This mechanism explains the rapid progression of left ventricular failure, the most common cause of death after the interventions with achieving the epicardial blood flow without ECG signs of reperfusion. The revealed microcirculation disorders reflect the absence of myocardial reperfusion, which is more prognostically significant than the restoration of epicardial blood flow.

19 October 2023 in Medical alphabet
Verified
Journal Article
Open access
PDF file
LTL. G. Tyurina
L. G. Tyurina
LKL. T. Khamidova
L. T. Khamidova
NRN. V. Ryubalko
N. V. Ryubalko
GGG. A. Gazaryan
G. A. Gazaryan
KPK. A. Popugaev
K. A. Popugaev
Echocardiography is one of the first-line methods of detection and evaluation of coronary artery disease, which helps clinicians in the diagnostic and prognostic evaluation of this disease. However, visual assessment of abnormal left ventricular myocardial wall motion is not always appropriate in detecting less severe or transient myocardial ischemia and in making an accurate differential diagnosis. Speckle-tracking echocardiography is a widely available non-invasive tool that can easily and quickly provide clarifying information and significantly extend the standard echocardiographic study, as the method allows you to identify subtle myocardial damage and local areas of ischemia that correspond to the pattern of coronary disease, and obtain an objective report in the form of simple visual scheme, very easy to use for differential diagnosis and treatment. Therefore, this method, which is increasingly used in various manifestations of coronary insufficiency and is convenient to use both at rest and with stress echocardiography, has proved efficient results in terms of predicting coronary heart disease, quantitative interpretation of emerging or persistent ischemia, assessment of the clinical course and outcome, and left ventricular remodeling. In this review, we have attempted to reflect the currently available findings that demonstrate the significance of speckle-tracking echocardiography for the evaluation and follow-up of coronary heart disease, including some congenital anomalies of the coronary arteries, and to touch on the main achievements and discoveries in the use of two-dimensional and three-dimensional deformation parameters and their potential application for a wider introduction into clinical practice.

18 August 2021 in Medical alphabet
Verified
Journal Article
Closed access
PDF file
GGG. A. Gazaryan
G. A. Gazaryan
GNG. A. Nefedova
G. A. Nefedova
LTL. G. Tyurina
L. G. Tyurina
IZI. V. Zakharov
I. V. Zakharov
AEA. S. Ermolov
A. S. Ermolov
The aim of the study was to assess the treatment results in patients with anterior STEMI using primary PCI in different patient age groups, including those at late hospitalization, taking into account the initial mortality risk (MR). The study included 804 patients with anterior STEMI, aged 28 to 91 years, who were admitted to N. V. Sklifosovsky Research Institute for Emergency Medicine in the period from 2008 to 2017: 583 of them had the primary PCI performed either within the first 12 hours from the disease onset (311 patients) or at late hospitalization: after 12–72 hours (272 patients); and 221 patients treated without PCI. The distribution of patients by age: under 65 years old, 65–75 years old, and over 75 years old was 340, 139, and 104 in the PCI group, and 126, 47, and 48 in the group without PCI, respectively. In 26 death cases after PCI and in 39 of died without interventions, the state of the coronary bed, the affected area, and the immediate cause of death were determined. We have found that in the absence of reperfusion therapy (RT) in STEMI, the initially high baseline MR assessed by TIMI Risk Score corresponds to high mortality. It affects people of predominantly elderly and, especially, senile age, who more often have a proximal lesion of the main coronary arteries, which causes an extensive area of infarction with the development of fatal complications. The use of primary PCIs, including those at late hospitalization, prevents the progression of acute heart failure, the formation of LV aneurysms, and reduces the deaths rate. In different periods of time, the mortality rate with the use of primary PCI, including the delayed ones, fluctuates; it can rise with a significantly increasing number of the hospitalized at senile age. An increase in mortality is associated with complications, including those arising during procedures in severe multivessel coronary artery disease, which is more common in this patient population. Achieving angiographic success even in the absence of ECG signs of reperfusion can significantly reduce mortality in all age groups. High MR is an optimal indication for using delayed procedures. An urgent use of primary PCIs, including those at late hospitalization, allows the optimization of the STEMI treatment, and the achievement of the maximum reduction in mortality.

24 April 2025 in Medical alphabet
Verified
Journal Article
Closed access
PDF file
MKM. U. Keshtova
M. U. Keshtova
GGG. A. Ghazaryan
G. A. Ghazaryan
SPS. S. Petrikov
S. S. Petrikov
Objective. To investigate the influence of arterial hypertension (AH) and ischemic heart disease (IHD) on the course and outcomes of COVID19, considering their various stages, forms, and target organ involvement.Materials and мethods. A total of 808 COVID19 patients hospitalized in the Intensive Care Unit (ICU) from October 1 to December 31, 2020, aged between 17 and 97 years, were examined. The first group consisted of 246 patients without comorbidities. The second group included 430 patients with AH: 305 with stage II and 125 with stage III. The third group comprised 132 patients with IHD and AH: 84 with angina pectoris, 24 with postinfarction cardiosclerosis, and 24 with acute myocardial infarction (AMI). Clinical and laboratory parameters were assessed for all patients, along with electrocardiography, echocardiography, Doppler ultrasound of the lower extremity veins, and computed tomography (CT) of the thoracic organs. In 110 deceased patients, the severity of lung involvement, signs of heart failure, and the immediate cause of death were evaluated.Results. Among COVID19 patients hospitalized in the ICU, the prevalence of AH was 70%, including 16.5% with IHD, and 22% had concomitant diabetes mellitus. The mortality rate among COVID19 patients without cardiovascular diseases (CVD) was 4.5%. Among those with Stage II AH, including those with IHD and angina, the mortality rates were 8.2% and 14.3%, respectively. In patients with stage III AH with renal or cardiac involvement, mortality rates were 24% and 62.5%, respectively.Conclusion. Risk stratification for mortality, considering the prognostically unfavorable significance of the stages and forms of AH and IHD, as well as concomitant viral infections with respiratory complications, allows for an objective assessment of disease progression and prognosis.